EFFECTIVENESS OF MAGNESIUM SULFATE IN TERM NEONATES HAVING PERINATAL ASPHYXIA

AA ALI; S SUBHANI; T ALI; J ANWER; M ARSHAD; MU AHMAD

doi:10.54112/bcsrj.v2024i1.1199

Authors

AA ALI Department of Paeds Medicine, Sheikh Zayed Medical College and Hospital Rahim Yar Khan, Pakistan
S SUBHANI Department of Paeds Medicine, Sheikh Zayed Medical College and Hospital Rahim Yar Khan, Pakistan
T ALI Department of Paeds Medicine, Sheikh Zayed Medical College and Hospital Rahim Yar Khan, Pakistan
J ANWER Department of Paeds Medicine, Sheikh Zayed Medical College and Hospital Rahim Yar Khan, Pakistan
M ARSHAD Department of Paeds Medicine, Sheikh Zayed Medical College and Hospital Rahim Yar Khan, Pakistan
MU AHMAD Department of Paeds Medicine, Sheikh Zayed Medical College and Hospital Rahim Yar Khan, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1199

Keywords:

Efficacy; Magnesium sulfate; Neonates; perinatal asphyxia

Abstract

In Pakistan, neonatal mortality and morbidity are remarkably high. Birth asphyxia (perinatal asphyxia) is one of the main contributors to this, apart from prematurity, sepsis and other causes. Objective: To assess the effectiveness of magnesium sulfate in term neonates having perinatal asphyxia Methods: This Randomized Controlled Trial was carried out at the Department of Pediatrics, Sheikh Zayed Hospital Rahim Yar Khan from July 2023 to December 2023. The overall sample size was 130 patients (65 patients in each group). Neonates in group A received MgSO through I/V, 3 doses 250mg/kg/dose, 24 hours apart along with standard treatment. Group B was a control group that received 20 ml of normal saline infusion at the same interval with similar supportive and symptomatic treatment with regular monitoring. The outcome in terms of mortality, seizure, early initiation of feed, time to the establishment of full oral feeding, duration of seizures and duration of hospital stay were assessed. All the data was analyzed by using SPSS version 25.Results: In the current study, a total of 130 neonates were enrolled. Among them, moderate asphyxia was observed in 90 (69.23%) patients whereas severe perinatal asphyxia was observed in 40(30.77%) patients. In group A, the mean level of serum magnesium in neonates with moderate asphyxia was 2.81 (±0.20) mEq/L while in neonates with severe asphyxia, it was 2.89 (±0.61) mEq/L. The moderate asphyxia patients in group-A showed significant statistical improvement in terms of seizure control (hours) (14.11±1.22 vs 18.11±1.56; P=0.01), normal cry appearance (Days) (11.1±0.12 vs 13.11±1.29; p=0.03), normal activity appearance (Days) (11.9±0.02 vs12.00±1.51; p=0.01), full oral feed acceptance by sucking (Days) (13.31±0.99 vs 14.61±1.51; p=0.01) and mean hospital stay duration (Days) (14.99±1.66 vs 16.21±1.11; p 0.02). Conclusion: Our study concludes that in asphyxiated newborns, postnatal magnesium sulphate infusion is safe and likely to enhance the short-term neurological prognosis in cases with moderate-grade encephalopathy.

Downloads

Download data is not yet available.

References

Siddiqui MA, Butt TK. Role of intravenous magnesium sulphate in term neonates with hypoxic ischemic encephalopathy in a low income country; a randomized clinical trial. J Coll Physicians Surg Pak. 2021;31(7):817-20.

Bayih WA, Tezera TG, Alemu AY, Belay DM, Hailemeskel HS, Ayalew MY. Prevalence and determinants of asphyxia neonatorum among live births at Debore Tabor General hospital, North central Ethiopia: a cross-sectional study. Afr Health Sci. 2021;21(1):385-96.

Sajid NK, Junaid M, Ahmed S. Therapeutic efficacy of magnesium sulphate on neurological outcome of neonates with severe birth asphyxia. J Uni Med Dent Coll. 2018;9(4): 1-5.

Ahmed R, Mosa H, Sultan M, Helill SE, Assefa B, Abdu M, et al. Prevalence and risk factors associated with birth asphyxia among neonates delivered in Ethiopia: a systematic review and meta-analysis. PLoS One. 2021;16(8):0255488.

Khan MH, Ann Q, Khan S, Ahmad N, Ahmed M. Efficacy of magnesium sulphate in addition to melatonin therapy in neonates with hypoxic-ischemic encephalopathy. Cureus. 2022;14(1):e21163.

Nonomura M, Harada S, Asada Y, Matsumura H, Iwami H, Tanaka Y, et al. Combination therapy with erythropoirtin, magnesium sulfate and hypothermia for hypoxic ischemic encephalopathy: an open label pilot study to asséss the safety and feasibility. BMC Pediatr. 2019;19:13.

Rashid A, Fatima N, Asim M, Khalid A, Ali AS. Role of magnesium sulphate inshort term neurological outcome of perinatal asphyxia. Pak Post Med J. 2015;26(1):2-5.

Savitha MR, Rajprakash. Beneficial effect of intravenous magnesium sulphate in term neonates with perinatal asphyxia. Int J Contemp Pediatr 2016;3:150-4.

Rasheed J, Khalid M, Maryam B, Parveen S. Effect of intravenous magnesium sulphate on in-hospital mortality in neonates with perinatal asphyxia: prospective cohort study. Ann King Edward Med Uni. 2023;29(2): 136-41.

Lingam, I., Robertson, N. J. Magnesium as a neuroprotective agent: a review of its use in the fetus, term infant with neonatal encephalopathy, and the adult stroke patient. Developmental neuroscience, 2018. 40(1), 1- 12.

Gathwala, G., Khera, A., Singh, J., & Balhara, B. Magnesium for neuroprotection in birth asphyxia. Journal of pediatric neurosciences, 2010. 5(2), 102.

Bhat, M. A., Charoo, B. A., Bhat, J. I., Ahmad, S. M., & Ali, S. W. Magnesium sulfate insevere perinatal asphyxia: a randomized, placebo-controlled trial. Pediatrics, 2009. 123(5), e764-e769.

Savitha, M. R., & Prakash, R. (2016). Beneficial effect of intravenous magnesium sulphate in term neonates with perinatal asphyxia. Int. J. Contemp. Pediatr, 3, 150-154.

Sreenivasa, B., Lokeshwari, K., & Joseph, N. Role of magnesium sulphate in management and prevention of short term complications of birth asphyxia. Sri Lanka Journal of Child Health, 2017. 46(2).

Ichiba, H., Tamai, H., Negishi, H., Ueda, T., Kim, T. J., Sumida, Y., ... & Minami For The Kansai Magnesium Study Group, H. Randomized controlled trial of magnesium sulfate infusion for severe birth asphyxia. Pediatrics International, 2002. 44(5), 505- 509.

Tagin, M., Shah, P. S., & Lee, K. S. Magnesium for newborns with hypoxic- ischemic encephalopathy: a systematic review and meta-analysis. Journal of Perinatology, 2013. 33(9), 663-669.